Teleflex, Inc. (TFX)

Sector:
INDUSTRIALS
Industry:
CONGLOMERATES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Benson F. Smith
Employees:
15,200
550 E SWEDESFORD RD, SUITE 400, WAYNE, PA 19087
610-225-6800

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates through the following business segments: Vascular North America, Anesthesia North America, Surgical North America, Europe, the Middle East and Africa, Asia and Original Equipment Manufacturer. The Vascular North America segment products facilitate a variety of critical care therapies, including the administration of intravenous medications and other therapies and the measurement of blood pressure and taking of blood samples through a single puncture site. The Anesthesia North America segment provides products for clinicians working primarily in emergency rooms, surgery and critical care settings. The Surgical North America segment products are predominantly comprised of single-use products, including ligation clips and closure products; appliers and sutures used in a variety of surgical procedures; access ports used in minimally invasive laparoscopic surgical procedures, including robotic surgery, and fluid management products used for chest drainage. The Europe, Middle East and Africa segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves two end markets: hospitals and healthcare providers, and home health. The Asia segment, designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The Original Equipment Manufacturer segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.

Data derived from most recent annual or quarterly report
Market Cap 13.845 Billion Shares Outstanding46.845 Million Avg 30-day Volume 361.257 Thousand
P/E Ratio55.6797 Dividend Yield0.3302 EPS4.26
Price to Revenue7.2702 Debt to Equity0.6659 EBITDA698.062 Million
Price to Book Value5.6358 Operating Margin17.0914 Enterprise Value21.481 Billion
Current Ratio2.728 EPS Growth-0.272 Quick Ratio1.473
1 Yr BETA 0.9459 52-week High/Low 448.11 / 289.0 Profit Margin13.0572
Operating Cash Flow Growth37.3172 Altman Z-Score4.0047 Free Cash Flow to Firm 91.342 Million
View SEC Filings from TFX instead.

View recent insider trading info

Funds Holding TFX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TFX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1 Thousand total shares from 2 transactions

Open Market Sells (S)

9 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

9 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HEINMILLER JOHN C

  • Director
2,414 2021-12-31 2

HICKS CAMERON P CORP. VP & CHIEF HR OFFICER

  • Officer
7,874 2021-12-31 6

KELLY LIAM CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
25,775 2021-12-27 4

KRAKAUER ANDREW A

  • Director
3,534 2021-11-30 2

DEREN JOHN CORP. VP & CAO

  • Officer
1,414 2021-08-24 3

KLASKO STEPHEN K. M.D.

  • Director
9,304 2021-07-12 2

RANDLE STUART A

  • Director
3,921 2021-06-04 2

BABICH GEORGE JR

  • Director
12,204 2021-05-04 1

HAGGERTY GRETCHEN R

  • Director
3,950 2021-05-04 1

PACKER RICHARD A

  • Director
3,784 2021-05-04 1

DUNCAN CANDACE H

  • Director
3,865 2021-05-04 1

WINTERS JAMES CORP VP, MFG AND SUPPLY

  • Officer
1,241 2021-04-23 2

POWELL THOMAS E EXECUTIVE VICE PRESIDENT & CFO

  • Officer
22,342 2021-03-02 2

LOGUE DANIEL V. VP, GENERAL COUNSEL, SECRETARY

  • Officer
11,800 2021-03-02 3

WHITE JAY VP & PRES, GLOBAL COMMERCIAL

  • Officer
6,411 2021-03-02 3

LEYDEN JAMES J VP, GENERAL COUNSEL, SECRETARY

  • Officer
No longer subject to file 2020-12-31 0

WIJKER MARIO VICE PRESIDENT, QARA

  • Officer
582 2020-02-25 0

SMITH BENSON

  • Director
47,861 2020-02-18 0

BOYLAN KAREN VP, GLOBAL STRATEGIC PROJECTS

  • Officer
2,258 2019-06-20 0

KENNEDY THOMAS ANTHONY SENIOR VP, GLOBAL OPERATIONS

  • Officer
2,863 2018-09-19 0

FOSTER W KIM

  • Director
3,580 2018-05-16 0

GRAVES JEFFREY A

  • Director
8,462 2017-05-09 0

BARRON PATRICIA C

  • Director
10,693 2017-02-23 0

COOK WILLIAM ROLAND

  • Director
20,195 2016-08-12 0

LUBSEN SIGISMUNDUS W W

  • Director
13,905 2015-03-16 0

YOH HAROLD L III

  • Director
10,277 2015-03-16 0

ZUG JAMES W

  • Director
10,694 2014-04-17 0

MILLER LAURENCE G EVP, CHF ADMIN OFF, GC & SEC'Y

  • Officer
43,928 2013-03-18 0

MEIER RICHARD A EXEC. VICE PRES. AND CFO

  • Officer
33,590 2012-02-28 0

NORTHFIELD VINCENT EXEC. VP - GLOBAL OPS-MEDICAL

  • Officer
No longer subject to file 2011-03-08 0

WILLIAMS CHARLES EDWARD CORP. CONTROLLER AND CAO

  • Officer
5,950 2011-03-04 0

SUDDARTH JOHN B PRES-AEROSPACE, COMM & MED OEM

  • Officer
17,460 2011-03-01 0

BLACK JEFFREY P CHAIRMAN, PRESIDENT, CEO

  • Officer
  • Director
No longer subject to file 2010-12-31 0

WAASER R ERNEST PRESIDENT - MEDICAL

  • Officer
20,518 2010-03-01 0

GABORIAULT RANDALL P SR. VICE PRES. & CHF INFO OFF

  • Officer
No longer subject to file 2009-12-31 0

GORDON KEVIN K EXEC. VICE PRES. & CFO

  • Officer
No longer subject to file 2009-12-31 0

VON SELDENECK JUDITH M

  • Director
1,908 2008-11-21 0

MCDOWELL JULIE SR. VP CORP. COMMUNIC.

  • Officer
430 2008-02-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KELLY LIAM - Director - Officer CHAIRMAN, PRESIDENT & CEO

2021-12-29 16:37:45 -0500 2021-12-27 M 6,711 $59.96 a 34,762 direct -0.7283 -1.2179 1.1605 3 -1.2179 6

KELLY LIAM - Director - Officer CHAIRMAN, PRESIDENT & CEO

2021-12-29 16:37:45 -0500 2021-12-27 M 6,711 $59.96 d 0 direct yes

KELLY LIAM - Director - Officer CHAIRMAN, PRESIDENT & CEO

2021-12-29 16:37:45 -0500 2021-12-27 M 2,276 $59.75 a 28,051 direct -0.7283 -1.2179 1.1605 3 -1.2179 6

KELLY LIAM - Director - Officer CHAIRMAN, PRESIDENT & CEO

2021-12-29 16:37:45 -0500 2021-12-27 M 2,276 $59.75 d 0 direct yes

KELLY LIAM - Director - Officer CHAIRMAN, PRESIDENT & CEO

2021-12-29 16:37:45 -0500 2021-12-27 S 8,987 $330.00 d 25,775 direct -0.7283 -1.2179 1.1605 3 -1.2179 6

KRAKAUER ANDREW A - Director

2021-12-02 16:57:39 -0500 2021-11-30 P 500 $307.00 a 3,034 direct 4.98 5.2651 6.7099 9.6684 21 0.0 1

KRAKAUER ANDREW A - Director

2021-12-02 16:57:39 -0500 2021-11-30 P 500 $307.46 a 3,534 direct 4.98 5.2651 6.7099 9.6684 21 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TELEFLEX INC TFX 2022-01-28 18:45:03 UTC -0.209 0.279 1900000
TELEFLEX INC TFX 2022-01-28 18:15:04 UTC -0.209 0.279 1900000
TELEFLEX INC TFX 2022-01-28 17:45:03 UTC -0.209 0.279 1900000
TELEFLEX INC TFX 2022-01-28 17:15:03 UTC -0.209 0.279 1900000
TELEFLEX INC TFX 2022-01-28 16:45:04 UTC -0.209 0.279 1900000
TELEFLEX INC TFX 2022-01-28 16:15:03 UTC -0.209 0.279 1900000
TELEFLEX INC TFX 2022-01-28 15:45:04 UTC -0.209 0.279 1900000
TELEFLEX INC TFX 2022-01-28 15:15:03 UTC -0.209 0.279 1900000
TELEFLEX INC TFX 2022-01-28 14:45:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-28 14:15:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-28 13:45:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-28 13:15:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-28 12:45:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-27 22:15:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-27 21:45:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-27 21:15:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-27 20:45:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-27 20:15:04 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-27 19:45:03 UTC -0.18 0.25 1900000
TELEFLEX INC TFX 2022-01-27 19:15:03 UTC -0.18 0.25 1900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advisors Series Trust- Pzena Long/Short Value Fund TFX -376.0 shares, $-136435.36 2020-05-31 N-PORT
FundVantage Trust- Gotham Absolute 500 Core Fund TFX -12.0 shares, $-3514.32 2020-03-31 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund TFX -235.0 shares, $-96718.95 2020-12-31 N-PORT
FundVantage Trust- Gotham Neutral 500 Fund TFX -38.0 shares, $-15787.48 2021-03-31 N-PORT
Nuveen Investment Trust- Nuveen Equity Market Neutral Fund TFX -550.0 shares, $-221204.5 2021-05-31 N-PORT
Nuveen Investment Trust II- Nuveen Equity Long/Short Fund TFX -1000.0 shares, $-395460.0 2021-08-31 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Anti-Beta Fund TFX -1160.0 shares, $-436798.0 2021-09-30 N-PORT
Legg Mason Global Asset Management Trust- Franklin Global Market Neutral Fund TFX -500.0 shares, $-188275.0 2021-09-30 N-PORT
INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund TFX -155.0 shares, $-58365.25 2021-09-30 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund TFX -12.0 shares, $-4518.6 2021-09-30 N-PORT
FundVantage Trust- Gotham Hedged Core Fund TFX -74.0 shares, $-27864.7 2021-09-30 N-PORT

Elevate your investments